Last updated: October 11, 2021
Sponsor: University Hospital, Strasbourg, France
Overall Status: Active - Recruiting
Phase
N/A
Condition
Circulation Disorders
Treatment
N/AClinical Study ID
NCT04593173
7905
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patient (≥18 years old)
- Type 2 diabetic and hypertensive subjects, cardiac asymptomatic, without myocardialischemia documented by Dobutamine stress ultrasound (ESD), having at least 1additional CV risk factor among: dyslipidemia, active or stopped smoking for less than 3 years, family history (1st degree relationship) of major CV accident before age 60,obliterating arteriopathy of the lower limbs and / or carotid atheroma, orproteinuria.
- Subject not having expressed his opposition, after information, to the reuse of hisdata for the purposes of this research.
Exclusion
Exclusion Criteria:
- Patient who expressed his opposition to participating in the study
- Valvular heart disease (moderate to severe valve disease), hypertrophic or dilated (MVGi> 95 g / m2 in women and MVGi> 115 g / m2 in men), chronic pulmonary;
- History of cardiotoxic chemotherapy;
- Subject under legal protection, under guardianship or under guardianship.
Study Design
Total Participants: 77
Study Start date:
October 01, 2020
Estimated Completion Date:
November 01, 2021
Connect with a study center
Service de Physiologie et d'Explorations Fonctionnelles
Strasbourg, Starsbourg 67091
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.